JSAM
DGX icon

J. Safra Asset Management’s Quest Diagnostics DGX Stock Holding History

J. Safra Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$979K Sell
4,621
-447
-9% -$87.7K 0.05% 121
2026
Q1 		$993K Buy
5,068
+23
+0.5% +$4.47K 0.05% 97
2025
Q4 		$875K Buy
5,045
+919
+22% +$167K 0.05% 112
2025
Q3 		$786K Buy
4,126
+590
+17% +$105K 0.05% 82
2025
Q2 		$635K Buy
3,536
+356
+11% +$61.8K 0.04% 83
2025
Q1 		$538K Buy
3,180
+1,226
+63% +$201K 0.04% 71
2024
Q4 		$295K Buy
1,954
+867
+80% +$135K 0.02% 93
2024
Q3 		$168K Buy
+1,087
New +$162K 0.02% 87

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

J. Safra Asset Management's DGX Position: Q2 2026 in Review

J. Safra Asset Management reduced its Quest Diagnostics (DGX) stake by 8.8% in Q2 2026, selling an estimated $87.7K and leaving 4,621 shares worth $979K. The position accounts for 0.05% of the portfolio, ranked #121.

J. Safra Asset Management first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. The position peaked at $993K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • J. Safra Asset Management held 4,621 shares of Quest Diagnostics worth $979K as of Q2 2026.
  • J. Safra Asset Management sold 447 Quest Diagnostics shares in Q2 2026, an estimated $87.7K.
  • Quest Diagnostics made up 0.05% of J. Safra Asset Management's portfolio in Q2 2026, its #121 holding.
  • J. Safra Asset Management first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
  • J. Safra Asset Management's Quest Diagnostics position peaked at $993K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.